This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

HENRY N. WAGNER, JR., M.D.; MOHAMED A. RAZZAK, M.D.; ROBERT A. GAERTNER, M.D.; WINSTON P. CAINE, JR., B.A.; O. THOMAS FEAGIN, B.A.

Arch Intern Med. 1962;110(1):90-97.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Labeling erythrocytes with radioactive chromium (Cr⁵¹) has made possible study of the fate of normal and diseased erythrocytes.¹ The ability of the spleen to sequester red blood cells has been demonstrated in numerous pathological states, the most prominent of which are hereditary spherocytosis, certain autoimmune hemolytic anemias, cirrhosis of the liver, and Gaucher's disease. In an effort to determine why some red cells are destroyed in the spleen while others are not, Harris, McAlister, and Prankerd studied the sites of destruction of red cells with both induced and naturally occurring abnormalities.² Spherocytes produced by heating red cells for 15 minutes at 50 C and red cells whose surface lipids had been reduced by alumina were selectively sequestered in the spleen after injection. Red cells in which metabolism had been inhibited by incubation in sodium arsenate were destroyed in areas other than the spleen. An extensive series of . . . [Full Text PDF of this Article]

Author Affiliations
BALTIMORE

Diagnostic Radioisotope Laboratory, The Johns Hopkins Medical Institutions.

Footnotes
Submitted for publication Aug. 24, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?